• Amyloid Beta-Peptide (1-40) (human)

  2026-08-13

  Amyloid Beta-Peptide (1-40) (human) is a synthetic 40-residue Aβ40 model for Alzheimer’s disease research. Its defined sequence, aggregation behavior, and documented solubility support amyloid fibril formation studies, neurotoxicity mechanism investigation, and controlled assay development.

• CHI3L1-IN-5: Reframing Astrocyte Repair in AD

  2026-08-13

  CHI3L1-IN-5, also known as Compound Z17, offers a differentiated strategy for Alzheimer’s disease research by coupling CHI3L1 pathway inhibition with restoration of astrocyte-mediated amyloid clearance and lysosomal function. This thought-leadership article examines the mechanism, experimental evidence, translational positioning, CNS-relevant properties, and practical development strategy for advancing Z17 beyond a conventional inflammatory assay.

• How HBsAg Rewires TBK1, Interferon, and Autophagy

  2026-08-12

  The reference study shows that hepatitis B surface antigen (HBsAg) redirects TBK1 activity away from IRF3-mediated interferon signaling and toward p62-associated early autophagy. Its combination of mechanistic interaction studies, pharmacologic perturbation, animal data, and human liver samples provides a framework for understanding how HBV may sustain immune evasion and incomplete autophagy.

• HCAR3 Cryo-EM Reveals Agonist Selectivity

  2026-08-12

  Ye and colleagues used cryo-EM structures and cAMP signaling assays to define how HCAR3 recognizes agonists and differs from HCAR2. The study identifies pocket geometry and residue-level interactions that may guide HCAR3-selective ligand design while reducing reliance on HCAR2-mediated effects.

• NF 449: Translating P2X1 Selectivity into Platelet Insight

  2026-08-11

  NF 449 offers translational researchers a precise way to interrogate ATP-driven P2X1 signaling in platelets. This thought-leadership analysis connects receptor pharmacology, assay design, thrombosis models, and antithrombotic agent research while defining the compound’s value beyond a conventional product page.

• Diminazene Aceturate: Research Uses and Evidence

  2026-08-11

  Diminazene Aceturate is a di-amidine trypanocidal compound used in trypanosome parasite research and parasitic infection research. Product specifications report high water and DMSO solubility, while a 2024 mouse study used the compound as a pharmacological ACE2 activator linked to MasR-Sirt1-mediated mitochondrial biogenesis.

• EDTA-Free Protease Inhibitor for OXPHOS Assays

  2026-08-10

  Learn how an EDTA-Free Protease Inhibitor preserves labile proteins and strengthens OXPHOS cancer assays. This guide connects protease control with LRPPRC–dasatinib study design, assay interpretation, and reproducible sample preparation.

• NLRP10, Keratinocyte Survival, and AD Barrier Function

  2026-08-09

  The reference study moves NLRP10 from an atopic dermatitis susceptibility signal to a functional regulator of epidermal homeostasis. Using human skin evidence and an air-lift skin-equivalent model, it shows that NLRP10 limits caspase-8-associated keratinocyte death while stabilizing p63 to support differentiation and barrier formation.

• LY-411575: From Mechanism to Translation

  2026-08-08

  LY-411575 offers a highly potent way to interrogate the shared γ-secretase biology of amyloid beta production and Notch signaling. This thought-leadership perspective connects biochemical potency with translational study design, using recent triple-negative breast cancer evidence to define opportunities, risks, and next-step experiments without overstating preclinical findings.

• (+)-Bicuculline: Practical GABAA Workflow Guide

  2026-08-07

  (+)-Bicuculline is a research tool for competitively antagonizing GABAA receptors and dissecting inhibitory neurotransmission, with reported effects on synaptic NMDA receptor signaling. This dossier-based guide focuses on solubilization, storage, controls, and interpretation; the compound is for controlled laboratory research only and is not intended for diagnostic, clinical, or therapeutic use.

• MPC-Regulated Lactate and Histone Lactylation in Tumor Immun

  2026-08-07

  This study uncovers how downregulation of mitochondrial pyruvate carrier (MPC) in colorectal cancer elevates lactate production, driving histone lactylation in dendritic cells and weakening anti-tumor immunity. The findings establish a metabolic-epigenetic axis that shapes tumor progression and responsiveness to immunotherapy.

• Nystatin (Fungicidin): Advanced Antifungal Workflows & Insig

  2026-08-06

  Nystatin (Fungicidin) empowers researchers tackling Candida and Aspergillus infections with robust, reproducible antifungal assays. This article distills practical protocol advances, troubleshooting strategies, and the latest mechanistic findings—ensuring your antifungal studies achieve new levels of precision and impact.

• Dabigatran Etexilate: Clinical Advances in Oral Thrombin Inh

  2026-08-06

  This review analyzes the pivotal innovation of Dabigatran etexilate as the first oral direct thrombin inhibitor approved for stroke and VTE prevention in nonvalvular atrial fibrillation. The reference study details its pharmacology, clinical efficacy, and advantages over traditional anticoagulants, providing a benchmark for contemporary anticoagulant research.

• (-)-Arctigenin as a MEK1 Inhibitor: Bridging Inflammation an

  2026-08-05

  Explore the multifaceted roles of (-)-Arctigenin as a MEK1 inhibitor and iNOS expression inhibitor, with a special focus on its interplay with tumor-associated macrophages and advanced breast cancer models. This article offers a deeper mechanistic perspective, integrating the latest evidence and practical assay considerations.

• L-Ornithine and the Liver–Brain Axis: Mechanistic Insights f

  2026-08-05

  Explore how L-Ornithine, a urea cycle intermediate, shapes the liver–brain metabolic axis and CNS toxicity mechanisms. This article uniquely analyzes recent mechanistic breakthroughs, enabling more precise assay design for amino acid metabolism research.

16216 records 1/1082 page Next 12345 下5页 Last page